Topical corticosteroids

被引:9
|
作者
Lebrun-Vignes, B
Chosidow, O
机构
[1] Grp Hosp Pitie Salpetriere, Serv Pharmacol, Ctr Pharmacovigilance, F-75013 Paris, France
[2] Grp Hosp Pitie Salpetriere, Serv Med Interne, F-75013 Paris, France
来源
关键词
D O I
10.1016/S0151-9638(04)93540-5
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Therapeutics in dermatology underwent complete change after the introduction of topical hydrocortisone in the Fifties. At the time, stronger derivatives than hydrocortisone were synthetised and the indications for topical corticosteroids were expanded. Around twenty different molecules, classified according to their strength, are currently available for prescription in France. Many inflammatory or tumoral skin diseases respond to these products. The choice of a topical corticosteroid (strength, vehicle...) and of its mode of application (technique, rhythm of application) is oriented by the context (dermatitis treated, localization) and must respect "Good clinical practice" guidelines so as to select the best benefit/risk ratio.
引用
下载
收藏
页码:39 / 48
页数:10
相关论文
共 50 条